INTERIM REPORT Period from January – September 2022
Peptonic Medical AB (publ) org nr 556776-3064 (www.spotlightstockmarket.com, ticker: PMED) GROUP 2022 THIRD QUARTER (Jul-Sep) · Net sales of products KSEK 12 180 (7 234) · Gross profit KSEK 7 137 (4 492), Gross margin 59% (62%) · Operating loss KSEK -7 786 (-9 856) · Adjusted operation loss excl. non-recurrent charge KSEK -7 286 (-9 856) · Loss per share SEK -0,04 (-0,05) 2022 FIRST NINE MONTHS (Jan-Sep) · Net sales of products KSEK 33 442 (25 948) · Gross profit KSEK 19 002 (16 061), Gross margin 57% (62%) · Operating loss KSEK -26 807 (-28